MS
My Size, Inc. (MYSZ)·Q4 2024 Earnings Summary
Executive Summary
- FY 2024 closed with revenue up 18% to $8.26M and net loss reduced 37% to $3.99M; Q4 revenue was approximately $1.46M, reflecting sequential deceleration vs Q3 as Orgad faced inventory constraints and seasonality .* Values retrieved from S&P Global.
- Results vs consensus: Q4 Primary EPS was a significant beat at ($0.18) vs ($0.65) estimate; revenue missed at $1.46M vs $2.50M estimate. Bold: EPS beat, Revenue miss.* Values retrieved from S&P Global.
- Liquidity strengthened with $3.0M gross proceeds from warrant exercises in Dec-2024, supporting Orgad expansion and R&D; FY-end cash rose to $4.88M (up 123% YoY) .
- 2025 outlook: management targeted ~$15M FY 2025 revenue and shifted Orgad expansion toward Europe after certification with a major retailer; FY 2024 preliminary revenue guide ($8.5M) was later reported at $8.26M .
- Stock narrative catalysts: EPS beat alongside top-line miss, improved cash runway, and Europe expansion should focus investor attention on execution in Orgad and uptake of Naiz Fit SaaS modules .
What Went Well and What Went Wrong
What Went Well
- Strong year: Revenue +18% YoY to $8.26M; cash more than doubled to $4.88M; equity +46% to $6.91M .
- SaaS traction: Over 100 fashion brands deployed Naiz Fit modules; management emphasized “positioned for continued growth through SaaS expansion and e-commerce excellence” . “We delivered 18% revenue growth and more than doubled our cash reserves…” – Ronen Luzon, CEO .
- Q4 EPS beat vs consensus: Primary EPS ($0.18) vs ($0.65) estimate; one covering estimate.* Values retrieved from S&P Global.
What Went Wrong
- Q4 revenue miss vs consensus: $1.46M vs $2.50M; one covering estimate.* Values retrieved from S&P Global.
- Q3 context flagged operational headwinds: gross margin pressure and a $631k goodwill impairment in SaaS Solutions; Q3 operating loss widened YoY, and management disclosed going-concern risk without new capital .
- Network/legal overhangs: ongoing Israel conflict risks disclosed as immaterial so far but potentially escalating; legal proceedings (North Empire settlement loss ~$40k; Shukron fire-related claim) add uncertainty .
Financial Results
Quarterly performance: sequential and YoY comparison
Notes: Q2 revenue and Q3 revenue/NI margin from 8-K/10-Q filings; other values and Q4 figures marked * are Values retrieved from S&P Global.
Year-over-year Q4 comparison
Notes: All values marked * are Values retrieved from S&P Global.
Segment breakdown (nearest available quarter – Q3 2024)
KPIs (SaaS/Platform highlights)
Guidance Changes
Earnings Call Themes & Trends
No Q4 2024 earnings call transcript was available for MYSZ; themes reflect Q2/Q3 filings and Q4 press releases.
Management Commentary
- “We delivered 18% revenue growth and more than doubled our cash reserves… positioned for continued growth through SaaS expansion and e-commerce excellence.” – Ronen Luzon, CEO .
- “Our 53% revenue growth and 61% increase in gross profit are clear indicators… reduction in operating and net losses demonstrates commitment to profitability.” – Q2 CEO remarks .
- “Strong revenue growth… $15M in 2025; certification with a major European retailer expands Orgad’s reach.” – Annual update .
- “Shift to FBA reduced exposure to inventory risk and contributed to operating efficiencies.” – MD&A .
Q&A Highlights
- No formal Q4 2024 earnings call transcript available; management disclosures were via 8-K/press releases and the 10-Q .
- Guidance clarifications: FY 2024 preliminary revenue ($8.5M) updated to reported $8.26M; FY 2025 target ~$15M reiterated in Dec-2024 communications .
- Liquidity/risk: $3.0M warrants exercised; going concern risk disclosed alongside plans to raise capital and reduce expenses .
Estimates Context
Note: Values marked * are Values retrieved from S&P Global.
Commentary: Despite the top-line shortfall vs consensus, EPS materially outperformed, implying cost discipline and/or mix effects. With only one covering estimate, near-term consensus may recalibrate lower on revenue while adjusting EPS upward given execution signals.* Values retrieved from S&P Global.
Key Takeaways for Investors
- Mixed print: EPS beat and revenue miss versus consensus; expect estimate dispersion to remain high given limited coverage and evolving Orgad mix.* Values retrieved from S&P Global.
- Liquidity runway improved with $3.0M warrant proceeds and FY cash at $4.88M; watch capital raising cadence given going-concern disclosure .
- Execution pivot to Europe (Orgad certification) is a key 2025 driver; monitor revenue conversion to the ~$15M target and inventory positioning .
- SaaS KPIs are compelling (conversion, returns, AOV); increased brand adoption supports medium-term margin uplift if scaled .
- Q3 impairment signals prudence in SaaS valuation assumptions; continued focus on cost controls and mix should support EPS normalization .
- Macro/geopolitical risks disclosed as immaterial to date but remain a monitoring item for operational continuity and capital access .
- Near-term trading: expect volatility around updates on Europe expansion milestones, any additional financings, and cadence of press releases guiding revenue trajectory .
Footnote: All values marked with * are Values retrieved from S&P Global.